Search

Neutrophils with immunoregulatory properties, also referred to as type-2 neutrophils (N2), myeloid-derived suppressor cells (MDSCs), or tumor-associated neutrophils (TANs), comprise a heterogeneous subset of cells that arise from unknown precursors in response to poorly understood cues. Here, we find that, in several models of liver autoimmunity, pharmacologically induced, autoantigen-specific T regulatory type-1 (TR1) cells and TR1-cell-induced B regulatory (B reg) cells use five immunoregulatory cytokines to coordinately recruit neutrophils into the liver and program their transcriptome to generate regulatory neutrophils. The liver-associated neutrophils from the treated mice, unlike their circulating counterparts or the liver neutrophils of sick mice lacking antigen-specific TR1 cells, are proliferative, can transfer disease protection to immunocompromised hosts engrafted with pathogenic effectors, and blunt antigen-presentation and local autoimmune responses via cathelin-related anti-microbial peptide (CRAMP), a cathelicidin, in a CRAMP-receptor-dependent manner. These results, thus, identify antigen-specific regulatory T cells as drivers of tissue-restricted regulatory neutrophil formation and CRAMP as an effector of regulatory neutrophil-mediated immunoregulation. [Display omitted] • Antigen-specific TR1 and TR1-induced B reg cells recruit and re-program liver neutrophils • Liver neutrophil re-programming is driven by TR1 and/or B reg -derived cytokines • The re-programmed liver neutrophils are immunoregulatory and transcriptionally distinct • CRAMP has a key role in the immunoregulatory properties of these liver neutrophils Umeshappa et al. show that pharmacologically induced, liver autoimmune disease-relevant antigen-specific TR1 cells and B reg cells recruit and re-program liver neutrophils into an immunoregulatory subset that blunts liver autoimmune inflammation via CRAMP. [ABSTRACT FROM AUTHOR]